Timothy Sullivan
Keine laufenden Positionen mehr
Karriereverlauf von Timothy Sullivan
Ehemalige bekannte Positionen von Timothy Sullivan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Corporate Officer/Principal | 01.01.2017 | 01.05.2020 |
| PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 | 01.01.2017 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.12.2012 | 01.06.2015 |
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 01.03.2010 | 01.12.2012 |
Ausbildung von Timothy Sullivan
| University of Notre Dame | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Japan | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ARCUS BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Börse
- Insiders
- Timothy Sullivan
- Erfahrung